Live Breaking News & Updates on Carl Kraus

Stay updated with breaking news from Carl kraus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q3 2023 Earnings Call Transcript

Operator: Good morning and welcome to the Aquestive Therapeutics Third Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. ....

Ernie-toth , Steve-wargacki , Jason-butler , Dan-barber , Carl-kraus , Bennett-watson , Ken-marshall , Nasdaq , Aquestive-therapeutics-inc , Exchange-commission-on , Most-valuable-financial-companies , Aquestive-therapeutics

Aceragen (ACGN) Announces Recommendation of Data Monitoring Committee in Terra Study

Aceragen (ACGN) Announces Recommendation of Data Monitoring Committee in Terra Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Carl-kraus , Department-of-defense-threat-reduction-agency , Data-monitoring-committee , Aceragen-inc , Nasdaq , Chief-medical , Defense-threat-reduction-agency , Fast-track-designation , Orphan-drug-designation , Qualified-infectious-disease-product ,

Idera Bolsters Rare Disease Portfolio with Aceragen Buyout

Two rare disease companies - Idera Pharmaceuticals and Aceragen - are merging to pursue the common goal of an FDA approval that could come as early as 2024. ....

Milano , Lombardia , Italy , Philadelphia , Pennsylvania , United-states , John-taylor , Carl-kraus , John-kirby , Daniel-salain , Us-defense-threat-reduction-agency , Idera-pharmaceuticals

Idera Pharma (IDRA) Acquires Aceragen

Idera Pharma (IDRA) Acquires Aceragen
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Milano , Lombardia , Italy , Australia , United-states , United-kingdom , James-geraghty , Ron-wooten , Carl-kraus , Daniel-salain , Maxine-gowen , Michael-dougherty

Biopharma deal: NovaQuest-backed Aceragen buys Arrevus

RESEARCH TRIANGLE PARK - The biopharmaceutical company Aceragen, which is backed by NovaQuest Capital Management, announced that it has acquired Arrevus, Inc., ....

John-taylor , Carl-kraus , Arrevus-inc , Novaquest-capital-management , Cystic-fibrosis , Chief-medical ,